|
Article Excerpt Amorphous materials in pharmaceutical formulations yield complex and challenging problems concerning the performance, processing and storage of these products. (1) The presence of amorphous materials can be wanted or unwanted, depending on the desired or undesired unique properties of the amorphous state. Additionally, during the processing of pharmaceutical solids (e.g., milling, spray drying, tablet compaction, wet granulation and lyophilization), various degrees of disorder in the form of crystal defects and/or amorphous regions may be generated. Even relatively low levels of amorphous material (<10%) may have a detrimental impact on the stability, manufacturability and dissolution characteristics of the formulated drug product. Amorphous materials are inherently metastable and tend to revert to a more thermodynamically stable, crystalline form. As this instability has a potentially negative impact on storage and drug potency, it is important to quantify and control the amorphous content of pharmaceutically relevant materials. For these reasons, investigating the amount and stability of amorphous material is critical.
Gravimetric vapour sorption methods have been widely used to study amorphous materials; for example, several different gravimetric vapour sorption techniques have been developed to quantify amorphous contents below 1%. (2-5) Also, gravimetric vapour sorption has been used to investigate moisture-induced phase changes, (6-8) as well as vapour-induced crystallization kinetics. (9-13) This paper outlines several recent applications of gravimetric vapour sorption techniques to characterize amorphous materials.
Instrumentation and methods
Gravimetric vapour sorption instruments are well-established methods for determining vapour sorption isotherms. These instruments measure the sample mass change as the vapour environment surrounding the sample is altered. An increase in mass is typically associated with vapour sorption, while a decrease is caused by vapour desorption. The vapour concentration...
|
|

More articles from Pharmaceutical Technology Europe
When the going gets tough ... pharmaceutical technology Europe (PTE) t..., April 01, 2009 Upcoming technologies to facilitate more efficient biologics manufactu..., April 01, 2009
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|